New vision for preventing & curing age-related diseases, James Peyer, Founder & CEO, Cambrian Bio

Synopsis: James Peyer, Ph.D., is the Founder and CEO of Cambrian Bio, a clinical-stage drug-development company focused on creating therapies to prevent and cure age-related diseases. James discusses the driving force behind his interest in aging biology and oncology, how his perspective on aging has changed over the years, his entrepreneurial journey, and what he hopes to achieve over the next decade with PipeCos such as Telos, Amplifier, and Tornado. He also discusses the inherent risk involved in drug development, how he manages the emotional aspects, and Cambrian’s vision for the future of drug development. Biography: James Peyer is the Chief Executive Officer and Founder of Cambrian Bio. He also holds multiple board and executive roles across Cambrian’s pipeline. He has spent his entire life dedicated to the mission of finding ways of preventing people from getting diseases like cancer and Alzheimer’s instead of waiting for people to get sick. James was previously Founder and Managing Partner at Apollo Ventures, the first global longevity-focused venture capital firm, investing across the US and Europe. Prior to Apollo, James was a biotech R&D specialist at the New York office of McKinsey & Company, serving major pharmaceutical clients. He earned his PhD in stem cell biology at University of Texas Southwestern Medical Center as a National Science Foundation Fellow and received his B.A. with special honors from the University of Chicago. Interested to learn more: Telos: https://www.telosbio.com/ Amplifier: https://www.amplifier-tx.com/ Tornado: https://www.tornado-tx.com/